{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T22:53:43Z","timestamp":1753052023635,"version":"3.41.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T00:00:00Z","timestamp":1615507200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>An early first full-time pregnancy substantially reduces the risk of developing breast cancer later in life. Extensive studies indicate that this protective effect is mediated by the pregnancy hormone human chorionic gonadotrophin (hCG).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this proof-of-concept study 33 women with a BRCA mutation received recombinant-hCG (r-hCG). A 4-mm breast biopsy was obtained before (T1) and after 12 weeks of r-hCG injections (T2), as well as 6 months later (T3). The tissue was examined using RNA-sequencing methodology to determine if the \u2018high-risk\u2019 transcriptomic signature was converted to a \u2018low-risk\u2019 signature as in an early first full-time pregnancy. A stringent clinical safety monitoring was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The r-hCG administration was well tolerated in all participants. No clinically relevant changes were observed. In 25 women, the RNA quality was good for RNA sequencing in all three breast tissue biopsies. In response to the r-hCG, we observed 1907 differentially expressed genes (DEGs) (1032 up, 875 down) at T2 vs. T1 and 1065 DEGs (897 up, 168 down) at T3 vs. T1 in the group of women (<jats:italic toggle=\"yes\">n<\/jats:italic> = 11) not using any hormonal contraceptives during the study. There was no response at T2 vs. T1 and a small number of DEGs, 260 (214 up, 46 down) at T3 vs. T1 in the group of 14 women using contraceptives.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In summary, r-hCG has a remarkable effect on the gene expression profile of breast tissues from BRCA1\/2 carriers who did not use any contraception. This opens an opportunity for a novel preventive strategy to reduce the incidence of breast cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cej.0000000000000664","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T05:06:11Z","timestamp":1614402371000},"page":"195-203","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers"],"prefix":"10.1097","volume":"30","author":[{"given":"Herman","family":"Depypere","sequence":"first","affiliation":[{"name":"Department of Gynecology, Breast and Menopause Clinic, University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanrong","family":"Su","sequence":"additional","affiliation":[{"name":"The Irma H Russo, MD-Breast Cancer Research Laboratory, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nhi","family":"Dang","sequence":"additional","affiliation":[{"name":"The Irma H Russo, MD-Breast Cancer Research Laboratory, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Poppe","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Stanczyk","sequence":"additional","affiliation":[{"name":"Departments of Obstetrics and Gynecology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaak","family":"Janssens","sequence":"additional","affiliation":[{"name":"European Cancer Prevention Organization, University of Hasselt, Hasselt, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Russo","sequence":"additional","affiliation":[{"name":"The Irma H Russo, MD-Breast Cancer Research Laboratory, Fox Chase Cancer Center-Temple Health, Philadelphia, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"R1-20250527","first-page":"437","article-title":"Treatment with human chorionic gonadotropin and risk of breast cancer.","volume":"4","author":"Bernstein","year":"1995","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.contraception.2019.07.002","article-title":"Breast levonorgestrel concentrations in women using a levonorgestrel-releasing intrauterine system.","volume":"100","author":"Depypere","year":"2019","journal-title":"Contraception"},{"issue":"Suppl 3","key":"R3-20250527","first-page":"5","article-title":"Elecsys immunoassay systems using electrochemiluminescence detection.","volume":"110","author":"Erler","year":"1998","journal-title":"Wien Klin Wochenschr"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10549-017-4557-1","article-title":"Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.","volume":"167","author":"Evans","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1089\/cmb.2012.0283","article-title":"Calculating sample size estimates for RNA sequencing data.","volume":"20","author":"Hart","year":"2013","journal-title":"J Comput Biol"},{"key":"R6-20250527","first-page":"77","article-title":"Human chorionic gonadotropin and inhibin induce histone acetylation in human breast epithelial cells.","volume":"20","author":"Jiang","year":"2002","journal-title":"Int J Oncol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/0002-9378(70)90523-5","article-title":"Tissue distribution of human chorionic gonadotropin.","volume":"106","author":"Kazeto","year":"1970","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20250527","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12282-012-0384-8","article-title":"Reproductive history and breast cancer risk.","volume":"19","author":"Kobayashi","year":"2012","journal-title":"Breast Cancer"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cellbi.2009.07.002","article-title":"Human chorionic gonadotropin (hCG) prevents the transformed phenotypes induced by 17 beta-estradiol in human breast epithelial cells.","volume":"33","author":"Kocdor","year":"2009","journal-title":"Cell Biol Int"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF01806150","article-title":"Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden.","volume":"38","author":"Lambe","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.theriogenology.2010.03.030","article-title":"Use of the immature rat uterotrophic assay for specific measurements of chorionic gonadotropins and follicle-stimulating hormones in vivo bioactivities.","volume":"74","author":"Lecompte","year":"2010","journal-title":"Theriogenology"},{"key":"R12-20250527","first-page":"857","article-title":"Luteinizing hormone\/human chorionic gonadotropin receptors in breast cancer.","volume":"57","author":"Meduri","year":"1997","journal-title":"Cancer Res"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.fertnstert.2019.01.036","article-title":"Variation in DNA methylation in the KvDMR1 (ICR2) region in first-trimester human pregnancies.","volume":"111","author":"Miranda Furtado","year":"2019","journal-title":"Fertil Steril"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0300-9629(75)80121-6","article-title":"Human chorionic gonadotrophin: comparative studies of ovarian uptake in mammals.","volume":"52","author":"Mizejewski","year":"1975","journal-title":"Comp Biochem Physiol A Comp Physiol"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1755-8794-5-46","article-title":"Defining the genomic signature of the parous breast.","volume":"5","author":"Peri","year":"2012","journal-title":"BMC Med Genomics"},{"key":"R16-20250527","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6923239","article-title":"Involvement of ovarian estradiol biosynthesis and pituitary FSH expression in the mechanism of human chorionic gonadotropin stimulation of uterine growth in immature female rats.","volume":"2","author":"Rafert","year":"2016","journal-title":"J Hormones"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/carcin\/11.10.1849","article-title":"Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis.","volume":"11","author":"Russo","year":"1990","journal-title":"Carcinogenesis"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1524-4741.2001.21033.x","article-title":"Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer.","volume":"7","author":"Russo","year":"2001","journal-title":"Breast J"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/ijc.27323","article-title":"Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.","volume":"131","author":"Russo","year":"2012","journal-title":"Int J Cancer"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s10815-018-1248-8","article-title":"Evidence for expression and functionality of FSH and LH\/hCG receptors in human endometrium.","volume":"35","author":"Sacchi","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2217\/bmt.13.16","article-title":"Mimicking pregnancy as a strategy for breast cancer prevention.","volume":"2","author":"Santucci-Pereira","year":"2013","journal-title":"Breast Cancer Manag"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/carcin\/18.9.1799","article-title":"Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death.","volume":"18","author":"Srivastava","year":"1997","journal-title":"Carcinogenesis"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"99","DOI":"10.29252\/ibj.23.2.99","article-title":"Early parity epigenetic footprint of FOXA1 gene body in normal breast tissue of Iranian women.","volume":"23","author":"Zendehbad","year":"2019","journal-title":"Iranian Biomed J"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:02:47Z","timestamp":1748361767000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CEJ.0000000000000664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000664","relation":{},"ISSN":["0959-8278"],"issn-type":[{"type":"print","value":"0959-8278"}],"subject":[],"published":{"date-parts":[[2021,3,12]]}}}